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Clinical Significance 
 
A nurse practitioner at the worksite can provide valuable health care services to enhance 
the health status of employees; in addition such an initiative also enhances the overall 




A Benefit-Cost Analysis of a Worksite Nurse Practitioner Program: First 
Impressions 
Objective: This study aimed to assess the initial impact of an on-site Nurse Practitioner (NP) initiative upon the health 
care costs (HCC) among 4,284 employees and their dependents.  Methods: The authors analyzed HCC by two methods. 
First, they compared annualized actual values for the first six months of the start-up year (2004) with those projected for 
2004 on the basis of claims paid in 2002 and 2003. Both aggregate and per-individual HCC were used as the basis for 
comparison. The difference in HCC between projected and observed values for 2004 was defined as the benefit of the NP 
program. In a second analysis, HCC were calculated using 2003 paid claims for Major Diagnostic Categories (MDC). 
These HCC were compared with those which would have been incurred, had off-site care been  utilized for the 
(annualized) number of such patients cared for by the NP in 2004, with the same MDC. The cost of the NP program was 
used as the denominator in calculating the benefit-to-cost ratio, using the savings in HCC estimated by the two above 
methods. Results: Annualized cost of the NP program was $82, 716. Savings in HCC using the first method were 
$1,313,756 per year, yielding a benefit-to-cost ratio of 15 to 1. Using the MDC analysis, the ratio was 2.4 to 1. This 
difference in ratios between the two estimates may partly be attributable to effects of other initiatives, such as the wellness 
program and the Nurse Health Line. The latter was begun 10 weeks prior to the NP program, is available at all times,  
and is intended to minimize the need for workers and families to seek high-cost care at hospital emergency departments. 
Conclusions: The first six months of a new NP initiative yielded substantial reductions in HCC which warrant further 
analysis over longer periods of observation. However, the initial estimates may understate the aggregate value of the 
program since it may also reduce on-site injury and illness patterns and improve productivity, end-points which were not 
assessed in this initial snapshot     (J Occup Environ Med 2005; 47:000-000) 
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Worksite Nurse Practitioner 
 
With the advent of higher medical care costs and productivity concerns increasing at more worksites in 
the past decade, a growing number of companies have developed in-house medical clinics with occupational 
health nurses, nurse practitioners, and other allied health professionals. These clinics exist in both mid-sized and 
large organizations. According to some of these companies, on-site medical clinics make sense to them in terms 
of both cost-containment and quality of health care provided to their employees.1 For example, an external audit 
of one company’s on-site clinics found that employees used fewer outpatient and inpatient services when 
adjusted by age, gender, and other demographics, than their peers in the community. Moreover, the company’s 
database showed the costs to run the clinic are significantly less than what the health plan would have been 
paying if employees were to have used community health care providers.2 Similarly, other organizations report 
their health care costs have risen just 6% annually over the past four years, translating into corporate health care 
spending that is 17% less than industry-related averages; another organization reported its on-site clinics saves 
the company more than one million dollars per year.3   
 
In early 2004, officials of a southeastern US industrial metal/plastics manufacturing firm and Carolinas 
Healthcare System (CHS) engaged in a contract to offer nurse practitioner (NP) services at the firm’s (1) 
administrative, (2) plastics, and (3) foundry locations. On June 17, 2004, a nurse practitioner was hired by CHS 
and placed at the firm to begin her official duties.  The NP’s official workload was distributed as follows: 
• 18 hours per week devoted to plastics division employees 
• 18 hours per week devoted to foundry division employees 
•  4 hours per week devoted to administrative division employees 
The primary goal of the NP is to provide primary care services to employees in a timely and cost-
efficient manner. The scope of her services includes writing prescriptions, administering medications, and 
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establishing treatment modalities for chronic conditions. Currently, only employees are eligible to receive on-
site medical care services from the NP at no out-of-pocket expense.  
 
Prior to the NP placement, employees and dependents with health plan coverage obtained all medical 
care from off-site medical care providers. However, since April 1, 2004, a 24/7 nurse advice line provided by 
CHS has been available to employees and dependents. The nurse advice line is primarily designed to (1) assist 
employees in selecting appropriate on-site and off-site medical care and (2) eliminate unnecessary emergency 
department visits.  
In order to determine the impact on the new NP placement on the firm’s medical care expenses, CHS 
retained the services of Chenoweth & Associates, Inc. (C&A).  
 
Methods 
 Based on the primary purpose of the NP initiative and the type of pre- and post-initiative data available 
to C&A, a benefit-cost analysis framework was used to evaluate the initial impact of the NP intervention. The 
primary purpose of benefit-cost analysis (BCA) is to determine whether a program is worth its cost.4 In essence, 
BCA is an economic tool with an emphasis on estimating the monetary value of everything. The monetary value 
of a project rests on two fundamental postulates: 
 
 Postulate 1:  The social value of an intervention is the sum of the values 
    of the project to the individual members of society [workplace] 
 
 Postulate 2:  The value of an intervention to an individual is equal to his  
    (fully informed) willingness to pay for the intervention. 
 
Making value judgments about the desirability of economic states is the thrust of welfare economics and the 
choice of a decision criterion is critical. A guiding rule in formulating criteria, at least in Western society, is that 
each individual’s preferences must (somehow) count in the evaluation of alternative economic states. While 
there are four popular decision criteria (Unanimity, Pareto Superiority, Majority Rule, Potential Pareto 
Superiority), the criterion used in benefit-cost analysis is the Potential Pareto Superiority  criterion. It states that 
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an increase in general welfare occurs if those that are made better off and still from some change could, in 
principle, fully compensate those that are made worse off and still achieve in welfare improvement. While this 
criterion provides the basis for the quantitative part of BCA, it poses problems in that potential compensation 
may not be actual compensation. 
Obviously, BCA is most appropriate when both benefits and costs can be tangibly measured in monetary 
terms. Nevertheless, some researchers warn that quantification shouldn’t be the sole basis for performing a 
benefit-cost analysis. They contend that just because some important factors are not easily measured, they 
should not be ignored or given a lesser value than factors that can be measured. For example, how can you 
accurately quantify the human pain and suffering by people with severe back pain or chronic depression?  In 
essence, BCA doesn’t pretend to introduce rigor and quantification when data originate on subjectivity, 
imprecision, or where quantification is not feasible. However, when costs and benefits can be quantified, a BCA 
can be used to judge the worth of a single intervention or provide comparisons on two or more interventions. 
 
 Overall, benefit-cost analysis provides meaningful data to the extent that any benefits can be accurately 
measured. Yet such noble benefits as human lives saved, preventing heart attacks, or easing chronic back pain 
are not easily translated into precise numbers. Interestingly, a human life was valued to be worth a mere $5,000 
nearly a Century ago. Moreover, should a monetary value even be placed on a human life? Although it is 
possible to calculate the direct costs of treating a heart attack victim or to discount a person’s future job 
earnings lost from a disability, try to imagine the technical and ethical implications of using a benefit-cost 
analysis beyond its intended scope. 
 
Performing a Benefit-Cost Analysis 
 
 The cost side of a benefit-cost analysis involves calculating the costs of all resources used in planning 
and implementing an intervention. In contrast, the benefit side of the equation involves calculating the 
monetary value of any positive outcomes [pre-placement medical costs vs. post-placement medical costs] that 
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can be quantified. Measuring benefits requires a number of different techniques. The effects of direct benefits 
are usually measurable using standard accounting reports and conventional financial analysis. However, the 
effects of indirect benefits on profitability can be very large, though difficult to prove using conventional cost-
accounting. 
 
Obviously, in order to prepare a workable BCA framework, it is essential to identify and measure benefits and 
costs. A sample listing of typical benefits and costs is as follows: 
 
Typical Benefit Items              vs.     Typical Cost Items 
  Fewer injuries/accidents                         Personnel 
  Fewer health care expenses                     Facilities 
  Fewer sick leave absences                Screening procedures 
  Greater productivity       Equipment 
 
 Presumably, calculating “direct” benefits associated with an intervention should be relatively simple. 
However, before any benefit can be calculated, evaluators must select benefit variables that are accessible and 
measurable, and feel confident that any benefit outcome is due primarily to the intervention. After all costs and 
benefits have been identified and measured, the two categories are monetarily compared. In most cases, the goal 
is to determine the “net benefit” of a particular intervention. In essence, if the value of the benefits minus the 
value of the costs is positive, then the analysis would indicate that the intervention is financially "worth the 
effort."  
 
 The net benefit of any intervention may be viewed in the following manner: 
  Net Benefit = [∑L$ + ∑GP + ∑PI] - C   where: 
 ∑L$ (sometimes called the direct benefit) stands for the reduction in 
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 medical care expenses due to a reduction of disease or disability.  
 For example, if the incidence of low back injury declines, then some 
 of the spending on physicians and other medical care services will no longer  
 be necessary and, thus, “saved” by the employer, society, or other payers. 
 ∑GP stands for the increase in general productivity, leading to greater 
 output and income. For example, if we reduce the incidence of low 
 back injury, we also increase the performance capabilities of the persons 
 involved (e.g., uninjured workers are more productive than injured workers)  
 so that they may continue to produce at desirable levels and earn their full paycheck.  
 ∑PI stands for the gain in working income due to reduced illness and  
 injury and their effects on absenteeism (lost income). Overall, GP and PI are  
 the “indirect benefits.  
 C stands for the cost of the intervention [e.g., a nurse practitioner]. 
Using a BCA framework, the cost of the NP placement was compared to any reduction in the firm’s 




The official date in which NP services were initiated at the firm was June 17, 2004. Thus, all direct costs 
associated with the NP placement were tracked from June 17, 2004 until December 31, 2004. Total direct costs 
for this timeframe were converted into a period of 12 months in order to provide an estimated annual cost. By 
factoring in all tangible costs associated with the NP placement and services to employees, a direct cost of 
$82,715.81 was computed on an annual basis.  
 
 Initially, it was necessary to establish an accurate baseline of the firm’s costs in the pre-NP placement 
years [2002 & 2003]. Essentially the retrospective claims payments in these years gave evaluators a relative 
baseline in which to compute projected 2004 payments without the NP placement intervention. Thus, medical 
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care claim charges and payment data for 2002 and 2003 were provided by the firm’s benefits department whom 
previously obtained these data from United HealthCare (The firm’s health plan administrator in 2004). A review 




Annual Claims, Charges, and Payments 
Medical, Allied Health, and Pharmacy (Combined) 
      2002   2003  % Change 
 
Covered Employees/Dependents   4,463   4,480   +.004% 
 
# Claims (Gross)    22,743   26,178  + 15.1% 
Claims per capita      5.09      5.84  + 14.7% 
 
$ Charges (Gross)        $ 9,768,888        $11,327,850 +15.9% 
Charges per capita              $ 2,188   $ 2,528 +15.5% 
 
$ Paid (Gross)        $ 5,496,850        $ 6,248,719 +13.7% 
$ Paid per capita              $ 1,231    $1,394 +13.4% 
 
Per capita=per individual covered employee/dependent 
 
Overall, table 1 shows substantial increases in both utilization and cost patterns despite virtually no 
change in the number of covered lives. Although it is important to acknowledge total [gross] claims and 
charges, evaluators chose to provide per capita distributions because they reflect measurable outcomes at the 
individual level. By and large, there was very little difference between gross percentage changes vs. per capita 
percentage differences from 2002 to 2003. 
 
 Once the preceding pre-NP placement utilization and cost patterns were quantified, evaluators 
developed an inflation index  [based on the 2002 and 2003 data] to estimate 2004 patterns without the services 
of a nurse practitioner. The number of covered employees and dependents differed in the two pre-placement and 
first intervention years. Thus, evaluators selected per capita percentage changes from 2002 to 2003 as a 
representative inflation index to use in calculating 2004 utilization and cost projections.  In applying per capita 
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percentage changes to the actual number of covered employees and dependents in 2004, it is projected that 
utilization and costs for 2004 would be as shown in Table 2. 
Table 2 
 
Health Care Cost Trends and Projections, 2002-2004 
 
       % Change        
         2003  [2002 vs. 2003] 2004 
Covered Employees/Dependents   4,480       -.038%  4,284   (actual) 
 
Claims per capita      5.84   + 14.7%    6.69 (projected) 
 
$ Paid per capita              $1,394   +13.4%           $1,580 (projected) 
 
 
 The 2004 projections provide a glimpse of the firm’s claims and payments without a nurse practitioner. 
The next step was to compare the projected 2004 profile [without a NP] against the actual 2004 profile [With an 
NP in place]. Table 3 provides a head-to-head comparison between the two scenarios. 
 
   
Table 3 
 
Yearly Payments and Claims 
 
             2004   2004            Difference 
     2003       Projected            Actual  Per Capita 
 Outcome    [Actual]  [Without NP]         [With NP]      [Without vs. With] 
 
$ Paid     $6,248,719 $7,104,793        $5,791,037       -$1,313,756 (-18.5%) 
Claims per capita     5.84         6.69   5.071  -1.62   (-24.2%) 
$ Paid per capita   $1,394     $ 1,580  $1,3512 -$229  (-14.5%) 
1 Based on eleven (11) months of 19,903 reported claims [from January 1 to November 30, 2004] - multiplied 
by 1.09 - to calculate a projected value of 21,712 annual claims. 
2 Based on eleven (11) months of $ 5,312,878 [from January 1 to November 30, 2004] - multiplied  by 1.09 -  to determine 





Overall, the preceding data show projected 2004 outcomes [without NP] were considerably higher than 
actual 2004 outcomes in all major categories. Percentage differences between the respective 2004 profiles are as 
follows: 
 • Actual payments were 18.5 lower than the projected norm. 
 • Actual per capita claims were more than 24 % lower than the projected utilization norm 
 • Actual per capita payments were more than 14% lower than the projected payment norm 
Projected vs Actual Cost Differences 
 
Overall, a cost difference of $1,313,756 exists between the projected 2004 medical payments [without 
the NP placement] vs. actual 2004 payments [with an NP]. Although it is possible to speculate that the 
preceding cost-difference may be twice the listed amount – since the NP was in place only 6 months – it is 
impossible to determine an actual annualized cost difference until an evaluation is conducted after the NP has 
been in place for a full 12 months. Yet, this cost difference only reflects a direct cost difference tied exclusively 
to medical care payments incurred in two different scenarios. Interestingly, the cost-difference does not factor in 
other “hidden costs” such as lost productivity if employees would have to leave work to seek health care 
services in off-site [community] health care settings. Nor does the cost difference factor in the number of lost 
time absences avoided by employees when they [would presumably] come to work because they have on-site 
health care services instead of staying home. These “hidden costs” have been studied by numerous 
organizations over the past decade. For example, one organization surveyed employees using the on-site 
medical clinic regarding: (1) whether they would have used an outside doctor if the corporate medical clinic 
were not available, and (2) how many days per year they estimated that they came to work because there was an 
on-site medical clinic when they would otherwise have stay at home. The results indicated that, on average, 
employees who used the facility saved 3.3 days of absenteeism. In addition, nearly 70% of employees indicated 
that they would have sought attention elsewhere, suggesting that the presence of an on-site medical center  does 
not induce demand.5 
Benefits vs. Costs 
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Overall, there was a difference of $1,313,756 between the firm’s projected 2004 payments vs. The 
firm’s actual 2004 payments. This “cost-avoidance” represents a tangible and measurable “benefit” that can be 
subjected to the following benefit-cost comparison: 
 
Benefit*  $ 1,313,756   $ 15.88  
---------- = ------------- = -----------  =   15.88  to 1 [ROI] 
Cost   $     82,716  $  1.00 
 
 
 The preceding benefit-to-cost ratio indicates the initial phase of the NP intervention generated a 
favorable level of cost-containment benefits at the firm. Yet, it should be noted that the 2004 claims and 
payment data were based on eleven (11) months of actual data and, thus, did not include claims and payments 
for the month of December. Although C&A extrapolated 11 months of data into an annual (full year) projection, 
there is some evidence that claims and payments are higher in the winter months than in other months.6-7 Thus, 
the only way to determine the most accurate benefit-to-cost ratio – within this initial methodological approach – 
would be to obtain all claims and payments relevant to the month of December. Statistically speaking, the 
preceding benefit-to-cost ratio of 15.88 to 1 would, at worst, be reduced no more than 1/12th  - based on the 
liberal assumption that utilization and payment patterns are twice as high in December as in preceding months.  
Even then, the ratio would be reduced to 14.55 to 1. 
 
As with any project in which econometric analyses are involved, it is important to compare the initial 
cost-to-benefit findings with those from another evaluative approach to objectively judge how the independent 
approaches differ and what, if any, contrasting outcomes result. This project lends itself to such options that can 
provide decision-makers with at least two alternative methods to evaluate the impact of the NP intervention.  
A Second Analysis 
 
Unlike the preceding approach which is a macro-analytical overview and comparison of projected vs. 
actual claims and costs conducted on an aggregate [group] population, this second approach was a bit more 
micro-analytical in that it takes into account:  
•  Actual conditions reported by individual employees within each of the three worksite locations 
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•  Estimated costs for the preceding conditions if they were treated off-site [without NP treatment] 
•  A cost comparison between treatments per specific condition without NP vs. with the NP 
Key procedures used to factor in the preceding components were undertaken in the following order: 
(1) 2003 MDC-specific claims and costs data were obtained from United HealthCare, were stripped of 
individual health information, and subsequently reviewed 
(2) Average payments per 2003 MDC-specific conditions were computed 
 (3) The # of specific conditions treated by the NP from June 21 to November 12, 2004 [23 weeks] was obtained 
from the NP 
(4) The number of actual treatments rendered in the preceding timeframe of 23 weeks was multiplied by 2.26 
[52/23] to provide an annual [12 months] projection 
(5) The projected number of treatments in 2004 was multiplied by the average 2003 cost per MDC to calculate 
an annual 2004 cost if treatments were done off-site [without NP] 
(6) The projected cost of 2004 off-site treatments [without NP] was compared to the estimated cost of 2004 on-
site treatments [with NP] to determine a “cost-savings benefit” 
(7) The“cost-savings benefit” [#6 above] was compared against projected 2004 medical costs (without NP)  
 
In performing thepreceding analyses, it was essential for evaluators to identify discrepancies regarding the 
classification of pre-NP [2003] claims data vs. the classification of conditions treated by the NP. For example, 
2003 claims data provided by United HealthCare were by Major Diagnostic Category (MDC). Yet, treatments 
rendered by the NP were formatted by international classification of disease (ICD). Due to this discrepancy, 
evaluators had to assign the ICD-based treatments to their respective MDC (e.g., ICD 401 was assigned to the 
MDC known as circulatory). 
 
Since virtually all of the conditions treated by the NP appeared to be acute and minor ailments, 
evaluators decided to limit their review of 2003 claims to conditions costing no more than $500. Thus, by 
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selecting relatively low cost claims [<$500], evaluators believed the average costs assigned to each MDC would 
not be artificially inflated by a small percentage of excessively high cost claims [“outliers”]. In addition, only 
the most common MDCs were included in this analysis. A review of claims data indicated that twelve (12) 
different MDCs comprised over 90% of all conditions treated by the NP during the study period [June 17, 2004 
to November 12, 2004.].  Table 4 shows a listing of the average payment and most common MDC conditions 
treated by the NP during this timeframe, in addition to estimated payments that the firm would have borne in 




Most Common MDCs, Average Payment per Claims, and 
Approximate Cost-Savings with NP Treatment 
 
 
   Average Payment   Estimated #    Estimated  
MDC   per Claim (2003)       Treatments (2004)4  Cost-savings5 
 Accid/injury/poisoning $ 111     63    $  6,993 
 Circulatory   $ 136   366    $49,776 
 Digestive   $ 212    81    $17,172 
 Endocrine/metabolic  $  95    22    $ 2,090 
 F.I.H.S.1   $190    43    $ 8,170   
 Genito-urinary  $112    34    $ 3,808 
 Infectious   $  69   137    $ 9,453 
 Musculo-skeletal  $ 159    54    $ 8,586 
 Nervous2   $ 125   142    $17,750 
 Respiratory   $ 135   251    $ 33,885 
 Skin/subcutaneous   $ 195   131    $ 25,545 
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 Signs/symp/ill-defined3 $ 154    93    $14,322 
          Total        1,354             $197,550 
1 Factors Influencing Health Status 
2 Includes ear and eye conditions 
3 SSI was not identified by MDC classification in the 2003 claims data; thus, an average payment of all other 
MDCs was computed and used as a default average for SSI. 
4 Based on multiplying the actual number of treatments rendered between June 17, 2001 – November 12, 2004 
by 2.26 [52 weeks divided by 23 weeks = 2.26]. 
5 The firm’s estimated cost-savings if treatments were rendered by an on-site nurse practitioner rather than off-
site health care providers. 
 
Overall, specific MDCs responsible for the greatest cost-savings potential were circulatory (25%), 
respiratory (17%), and skin and subcutaneous (13%). 
The final computation conducted in this alternative analysis was a head-to-head dollar comparison of the 
annual cost for the nurse practitioner compared to the estimated annual cost-savings. Comparing direct costs 
tied to an annual placement of a nurse practitioner at the firm with the estimated “cost-savings” yields the 
following: 
 
Cost-savings  $ 197,550                      $ 1.00 
-------------------------------------------------------       =           --------- 
NP Cost  $   82,716                    $  .42 
 
Overall, the preceding micro-analytical review of costs and benefits indicates the firm is saving $1 for every 42 
cents spent for on-site nurse practitioner services – or a savings-to-cost ratio of 2.38 to 1. 
In summary, this micro-analytical review of the NP placement indicates a more conservative, yet 
favorable, cost-to-benefit ratio than the initial macro-analytical approach.  
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Overall, the financial comparisons described and illustrated on the preceding pages reveal the following 
benefit-to-cost ratios and return-on-investment percentages: 
   Benefit $  Cost  $  R.O.I.  Median ROI 
Methodology # 1          $ 1,313,756      $ 82,716        15.88 to 1 
    --------------  ----------         -----------    9.13  to 1       
Methodology # 2  $   197,550  $ 82,716        2.38 to 1 
 
 
At a minimum, the firm’s on-site nurse practitioner generates nearly 2.4 times more than costs. In addition, 
there has been a steady increase in the number of monthly on-site treatments since the inception of the NP 
placement. Subsequent evaluations are planned in 2005 and 2006 to determine if this initial trend is sustained 
and, if so, what impact it may have on the organization’s medical care costs. 
 
Discussion 
The quest for control of health care costs and quality is leading some employers to establish on-site 
clinics and other initiatives that employ health professionals. A recent editorial in this Journal8  estimated that 
lost work-days for chronic medical conditions cost United States employers 73 billion dollars per year,  in 
addition to costs of lost productivity as well as the out-of-pocket medical expenses which they bear. Among 
strategies to cope with these increasing costs, a growing number of companies have introduced in-house 
medical clinics staffed by full-time nurse practitioners, occupational health nurses, physicians and other health 
professionals. However, there is little published information on the balance between the cost of such initiatives 
and their benefits. Our analysis focused on the initial benefit-to-cost experience of a pilot program in which a 
NP was recruited to provide on-site care for minor illnesses, as well as improve management of chronic medical 
conditions of “1200”  employees and “3084” dependents whose health insurance is subsidized by a three-site 
plastic pipe and foundry company.  The new program shows promise for yielding positive monetary results. The 
size of the initial cost saving is sensitive to the method of analysis employed.  That is, the annualized savings in 
HCC was $1,313,756, using the projected HCC based on the actual ones for 2002 and 2003. A smaller savings 
estimate ($197,550 per year) resulted from an analysis based on Major Diagnostic Categories and their mean 
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cost per claim, when treated by community health care providers. Using the NP program cost of $82,716 per 
year, the respective ratios of benefit-to-cost are 15 to one and 2.4 to one.  Neither analysis takes a credit for 
possible savings in productivity or other workplace benefits.   
 
Our report has obvious weaknesses, the main one being the use of only six months of experience. Hence, further 
experience with the NP program is needed to refine this analysis and judge overall program impact. At this 
stage, our methodology did not enable us to apportion benefits from other interventions such as the advent of 
the CHS Nurse Health Line (NHL) and the company’s Wellness Program. The latter program includes health 
risk appraisals with monetary inducements for participation, health fairs, onsite determination of serum 
lipoproteins and other analytes with reports to be given to personal physicians, and subsidized mammograms. 
However, we note that this program was already underway prior to the addition of the NP. It is possible that a 
future report will include an analysis of visits to hospital emergency departments and urgent care centers, 
enabling comparison of usage patterns prior to the NHL (4/1/2004) and NP (6/17/2004) initiatives. Essentially, 
this expanded evaluation would permit us to see month-to-month, 12-month comparisons both to projections 
and to previous year actual costs. It is also possible, however, that these initiatives may experience some 
adverse outcomes with negative monetary or other consequences that did not occur during this start-up phase. 
Should such occur, the reactions on the part of attending physicians of the involved workers or family members 
could be quite negative. However, we endeavor to consult with personal physicians in all cases where other than 
minor illnesses occur, and to refer worker-patients promptly in such cases. Often, the workers do not have 
personal physicians, in which cases we identify such resources convenient to their homes and arrange for early 
appointments.  
 
The MDC analysis we employed also carries certain limitations. For example, the $500 cut-off for claim 
costs may give an obvious disadvantage to the NP. The real savings of an on-site NP program may be in 
preventing claims that have escalated unnecessarily, either by early treatment and prevention, or by preventing 
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trips to a hospital emergency room. Furthermore, these small claims represented a small percentage of toal 
costs, thus raising doubt if an on-site NP program would, in actuality and over time, be limited to only 
impacting a small subset of total claims and costs. 
As an additional limitation, our experience with the NP and NHL programs may lack general 
applicability, being based in three urban North Carolina locations of a single company engaged in the foundry 
and plastic business, and which had on-site Occupational Health Nurses at both of its manufacturing sites. Many 
of the employees of the company live at substantial distances from the worksites, driving an hour or more each 
way. At times, long working hours make it difficult for individual workers to access health care off-site. Our 
findings may therefore not apply to other groups of workers with different logistics and personal habits. Other 
employers will need to make careful assessments of the benefits and possible disadvantages of on-site programs 
similar to the ones described herein. 
 
From the perspective of health care organizations, it may seem counter-intuitive for such an entity to help 
design and implement lower-cost options for delivering such care, as well as preventive medicine measures. 
However, it strikes us as essential that those entrusted with the care of the community must support efforts to 
improve such care and to optimize its benefit-to-cost function. And, to do so in measurable ways.  CHS 
therefore plans to continue its efforts to partner with employers in this regard, including optimizing the 
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